Concepedia
Statistics
Publications
11
Citations
383
H-Index
Active since
1998
Affiliations
Istituto Oncologico Romagnolo(Current)
Ospedale G.B. Morgagni - L.Pierantoni
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
University of Bologna
Luca Ricotti is an author at Istituto Oncologico Romagnolo specializing in medicine, oncology, and pharmacology.
Publications per year
1998–2005
Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines
Wainer Zoli, Paola Ulivi, Anna Tesei et al. · Breast Cancer Research · 2005 · 88 citations · Full text
Medicine, Oncology, Pharmacology +17
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines
Wainer Zoli, Luca Ricotti, F. Barzanti et al. · International Journal of Cancer · 1999 · 72 citations
Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer
Wainer Zoli, Luca Ricotti, M. Dal Susino et al. · British Journal of Cancer · 1999 · 54 citations · Full text
Medicine, Oncology, Pharmacology +15
In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.
Luca Ricotti, Anna Tesei, Franca De Paola et al. · PubMed · 2003 · 38 citations
In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines.
Anna Tesei, Luca Ricotti, Franca De Paola et al. · PubMed · 2002 · 28 citations
1–5 of 11